Product image of Oliclinomel N8-800 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin) supplied by GNH India

Oliclinomel N8-800

Active Ingredient:
Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin
Origin:
EU

Oliclinomel N8-800 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Oliclinomel N8-800, is a amino acid supplement presented as a parenteral nutrition intravenous solution for intravenous use. It supports protein synthesis and metabolic needs in patients who cannot receive enteral feeding.

GNH India supplies Oliclinomel N8-800 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Baxter Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Oliclinomel N8-800, an amino acid solution used in parenteral nutrition, addresses several clinical situations:

  • Parenteral nutrition (enteral feeding intolerance): Provides essential amino acids for patients who cannot receive enteral nutrition.
  • Post‑operative care (surgical recovery): Supports protein synthesis and nitrogen balance after major surgery.
  • Critical illness (intensive care): Supplies amino acids to critically ill patients to maintain metabolic function.

How It Works

  • Oliclinomel N8-800 delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. The amino acids serve as substrates for protein synthesis, replenish nitrogen stores, and support gluconeogenesis and other metabolic pathways. By bypassing the gastrointestinal tract, the solution ensures rapid availability of these building blocks in patients who cannot tolerate oral or enteral nutrition.

Side Effects

Adverse reactions may occur with intravenous amino acid solutions.

Common Side Effects

  • Electrolyte imbalance: mild shifts in sodium, potassium or calcium levels.
  • Hyperglycemia: transient rise in blood glucose during infusion.
  • Mild nausea or vomiting: occasional gastrointestinal discomfort.
  • Local infusion site irritation: redness or discomfort at the catheter site.

Serious or Rare Side Effects

  • Anaphylactic reaction: severe allergic response requiring immediate intervention.
  • Severe metabolic acidosis: significant pH changes in blood.
  • Renal dysfunction: impaired kidney function in susceptible patients.
  • Thrombophlebitis: inflammation and clot formation in the vein.

Precautions & Warnings

When using Oliclinomel N8-800, consider the following precautions:

  • Renal impairment: monitor renal function and adjust infusion rate.
  • Liver disease: use with caution due to altered amino acid metabolism.
  • Electrolyte disorders: correct existing imbalances before administration.
  • Hyperammonemia: avoid in patients with urea cycle defects.
  • Pregnancy: limited data; weigh benefits against potential risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Potential drug interactions should be reviewed before initiating therapy.

Major Interactions (Avoid)

  • Concurrent high‑dose amino acid solutions: risk of nitrogen overload.
  • Incompatible IV solutions containing calcium or phosphate: precipitation risk.

Moderate Interactions (Monitor Closely)

  • Insulin therapy: may require dose adjustment due to glucose changes.
  • Diuretics: monitor electrolyte balance closely.
  • Renal replacement therapy: may affect amino acid clearance and require dosing review.

Frequently Asked Questions

Oliclinomel N8-800 is an intravenous amino acid solution used as part of parenteral nutrition. It provides essential amino acids to patients who cannot receive enteral feeding, supports protein synthesis after surgery, and helps maintain metabolic balance in critically ill individuals.

The blend supplies a complete set of essential and non‑essential amino acids directly into the bloodstream. These amino acids act as building blocks for protein synthesis, replenish nitrogen stores, and support metabolic pathways such as gluconeogenesis, thereby sustaining tissue repair and energy production when oral intake is not possible.

The prescribed dose of Oliclinomel N8-800 is determined by the treating clinician based on the patient’s weight, clinical condition, renal and hepatic function, and nutritional requirements. The healthcare professional calculates the appropriate infusion rate and total daily amount.

Safety data for Oliclinomel N8-800 in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the prescribing physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Oliclinomel N8-800 offers a balanced profile of ten essential amino acids, matching or exceeding the composition of many standard parenteral amino acid formulations. Its EU‑origin manufacturing ensures compliance with stringent quality standards, and it is designed for compatibility with common parenteral nutrition regimens.

The solution must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Keep the container in its original packaging until use and discard any product that appears discolored or contains particles.

Oliclinomel N8-800 is administered intravenously, typically via a central or peripheral venous catheter. The infusion rate is set by the clinician based on the patient’s nutritional plan and monitored continuously for tolerance and metabolic response.

Serious risks include anaphylactic reactions, severe metabolic acidosis, renal dysfunction, and thrombophlebitis. Patients should be closely monitored for signs of allergic response, changes in blood pH, kidney function, and any vascular complications during and after infusion.

Patients with known hypersensitivity to any of the amino acids in the formulation, those with uncontrolled hyperammonemia or urea‑cycle disorders, and individuals for whom a compatible intravenous solution is unavailable should not be given Oliclinomel N8-800.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT